bmiMD Cost 2026: Semaglutide, Tirzepatide, Prepaid Plans, and Billing

Quick answer: How much does bmiMD cost?

As of September 10, 2026, bmiMD advertises compounded semaglutide from $119 per month equivalent and compounded tirzepatide from $179 per month equivalent. Those two lowest numbers require 12-month prepaid plans.

The current true one-cycle prices shown on bmiMD’s treatment pages are $159 for semaglutide and $249 for tirzepatide. bmiMD’s help center says monthly subscriptions renew every 28 days, while 3-, 6-, and 12-month plans are charged upfront for the full plan cycle.

That makes the amount charged today more useful than the headline monthly equivalent when comparing bmiMD with another provider.

Affiliate disclosure: Care Path Compare may receive compensation if you use a bmiMD link and make a qualifying purchase, at no extra cost to you. Compensation does not determine our editorial conclusions.

bmiMD semaglutide pricing

bmiMD’s current compounded-semaglutide page lists four plan lengths:

The $119 figure is therefore not a $119 month-to-month subscription. It is the effective monthly price obtained by paying $1,428 for a 12-month cycle.

The same distinction applies to the 6- and 3-month prices. A lower monthly equivalent means a larger upfront commitment.

bmiMD tirzepatide pricing

The current compounded-tirzepatide page lists:

Again, $179/month is a monthly equivalent attached to the 12-month prepaid price, not the amount charged one month at a time.

For a fair provider comparison, compare the upfront plan total, renewal timing, included services, and cancellation exposure—not only the lowest advertised monthly number.

What appears to be included in the price?

bmiMD’s current treatment pages describe the GLP-1 program price as including the telehealth provider visit, prescription treatment if the clinician determines it is appropriate, pharmacy fulfillment, shipping, refills, and ongoing provider messaging.

The company’s Terms say the single total subscription price can include amounts attributable to the pharmacy, medical group, and bmiMD platform. The consumer sees one total rather than separate invoices for each component.

Laboratory testing is less clear. bmiMD references metabolic testing when needed, but the public pages we reviewed do not provide one universal lab-cost rule for every GLP-1 customer. Ask whether labs are required for your pathway and whether any test cost is included.

How bmiMD’s 28-day monthly billing works

bmiMD’s help center says monthly subscriptions auto-renew every 28 days from the initial purchase date.

That is important because a 28-day billing cycle is not the same thing as billing on the same calendar date every month. Consumers should use the next-billing date displayed in their bmiMD account rather than assume a calendar-month renewal.

The help center also says subscription pricing stays locked at the signup rate unless the consumer changes plans. Recheck that language at checkout because promotional and plan terms can change.

How prepaid 3-, 6-, and 12-month plans work

bmiMD says multi-month plans are paid upfront in one charge and renew for another cycle at the end of the selected plan period.

Its refill guidance says injection-program shipments can still arrive one vial at a time during the prepaid period. Paying for several months upfront therefore does not necessarily mean receiving the entire medication supply in one shipment.

Before choosing a prepaid plan, confirm:

• Total amount charged today.
• Number and timing of shipments.
• Next renewal date and expected renewal amount.
• Whether the plan can be paused without losing the current price.
• What happens to unused prepaid value if treatment changes or stops.

What happens if the clinician does not approve treatment?

bmiMD’s current refund policy says the card is authorized after an order is submitted. Payment is captured after a licensed provider confirms eligibility. If the provider determines the consumer is not eligible for the selected program, bmiMD says the authorization is released and no charge is processed.

That policy is more consumer-friendly than treating the full medication purchase as final before clinical review, but consumers should still verify the exact checkout flow and authorization amount.

bmiMD’s $50 cancellation fee

The public wording deserves careful reading because bmiMD’s pages are not perfectly consistent.

The current refund policy says a non-refundable $50 cancellation fee can apply after the medical intake has been sent. bmiMD’s help-center cancellation article more narrowly describes a $50 medical review and administrative fee for an initial-order cancellation after provider approval but before pharmacy processing.

Because those descriptions differ, we would not assume one interpretation controls every order. If cancellation flexibility matters, ask bmiMD to confirm in writing:

• When the $50 fee starts applying.
• Whether it applies before clinician approval.
• Whether it applies to renewals or only an initial order.
• The last point at which the remaining payment can still be refunded.

When do refunds stop being available?

bmiMD’s policies generally become more restrictive once an order reaches pharmacy processing or fulfillment. Prescription products that have already been processed or shipped are described as non-refundable, and medication returns are not accepted.

This matters more with prepaid plans because the consumer commits a larger amount upfront. Before paying $447, $774, $1,428, $687, $1,134, or $2,148 for a multi-month cycle, understand how the policy would apply if the clinician changes the plan, treatment stops, or a future shipment is no longer wanted.

Does bmiMD use compounded medication?

The semaglutide and tirzepatide plans discussed on this page use compounded medications. Compounded drugs are not FDA-approved finished drug products and are not reviewed by FDA for safety, effectiveness, or quality before marketing in the same way FDA-approved drugs are.

Cost should therefore not be the only comparison factor. Consumers should also verify the clinician, actual dispensing pharmacy, formulation, concentration, storage and shipment instructions, and whether an FDA-approved treatment is an appropriate alternative to discuss with a licensed provider.

Which bmiMD plan is cheapest?

By displayed monthly equivalent, bmiMD’s 12-month prepaid plans are currently the lowest-priced options on both major GLP-1 treatment pages:

• Semaglutide: $119/month equivalent, $1,428 prepaid total.
• Tirzepatide: $179/month equivalent, $2,148 prepaid total.

By lowest upfront commitment, the one-cycle plans require much less cash at checkout:

• Semaglutide: $159.
• Tirzepatide: $249.

Those are different meanings of “cheapest.” A long prepaid plan can minimize the effective monthly price while increasing the amount of money committed before future treatment and service needs are known.

Questions to ask before paying bmiMD

• What exact amount will my card be charged today?
• Is this a 28-day recurring plan or a prepaid 3-, 6-, or 12-month plan?
• What is my next renewal date and expected renewal amount?
• How many shipments will I receive during the prepaid period?
• Does the $50 cancellation fee apply to my order, and when does it begin?
• At what point does my payment become non-refundable?
• Which pharmacy will fill my prescription?
• Are labs required, and are they included in the quoted price?
• Is the selected GLP-1 pathway available in my state?
• What happens financially if the clinician later changes or stops treatment?

Bottom line

bmiMD’s pricing can look inexpensive when viewed only as a monthly equivalent, but the prepayment structure is the key detail. Current semaglutide pricing ranges from $159 for one cycle to a $119 monthly equivalent on a $1,428 prepaid 12-month plan. Current tirzepatide pricing ranges from $249 for one cycle to a $179 monthly equivalent on a $2,148 prepaid 12-month plan.

Before choosing a plan, compare cash due today, billing cadence, renewal date, refund exposure, pharmacy information, and included care. For broader provider due diligence, read our full bmiMD review.

Medical disclaimer: This page is for consumer education and cost comparison only. It does not provide medical advice, diagnose conditions, or determine eligibility for prescription medication. Eligibility and treatment decisions are made by licensed healthcare professionals. Compounded medications are not FDA-approved finished drug products; discuss risks, benefits, alternatives, and appropriate treatment with a licensed clinician.